Guidelines International Network | Guidelines International Network (GIN)

Patient avec un trouble bipolaire : repérage et prise en charge initiale en premier recours

MeSH Terms: Bipolar Disorder (F03.600.150.150); Early Diagnosis (E01.390)
Publication Scope: assessment; counselling; implementation; management; patient_education; prevention; prognosis; rehabilitation; screening; treatment
Countries of Application: France
Guideline Publication Status: Published
Languages: French
Authors: HAS (FR)
Publication Year: 2015

MeSH Terms: Mohs Surgery (E04.494.575); Consensus Development Conference (V03.300); Melanoma (C04.557.465.625.650.510); Carcinoma; Basal Cell (C04.557.470.200.165)
Guideline Contact: Cindy Walker-Dilks ([email protected])
Publication Scope: treatment
Countries of Application: Canada
Guideline Publication Status: Published
Languages: English
Authors: McMaster University (CA)
Publication Year: 2018

MeSH Terms: Drug Labeling (E05.916.310); Medication Errors (E02.319.529); Antineoplastic Agents (D27.505.954.248)
Guideline Contact: Cindy Walker-Dilks ([email protected])
Publication Scope: treatment
Countries of Application: Canada
Guideline Publication Status: Published
Languages: English
Authors: McMaster University (CA)
Publication Year: 2009

MeSH Terms: Diagnostic Imaging (E01.370.350); Life Change Events (F01.829.458.410); Patients (M01.643)
Publication Scope: screening
Countries of Application: Australia
Guideline Publication Status: Published
Languages: English
Authors: JBI (AU)
Publication Year: 2012

MeSH Terms: Signs and Symptoms (C23.888); Low Back Pain (C23.888.646.172.500)
Guideline Contact: Asun Gutiérrez Iglesias ([email protected])
English Title Translation: MODELS OF LOWER BACK PAIN: RELIABILITY OF A CLASSIFICATION MODEL
Publication Scope: management
Countries of Application: Spain
Guideline Publication Status: Published
Languages: Spanish
Authors: OSTEBA (ES)
Publication Year: 2008

MeSH Terms: Carcinoma, Large Cell (C04.557.470.200.260); Carcinoma, Non-Small-Cell Lung (C04.588.894.797.520.109.220.249); Adenocarcinoma of Lung (C04.557.470.200.025.022); B7-H1 Antigen (D12.776.465.625); Programmed Cell Death 1 Receptor (D12.776.465.844)
Guideline Contact: Christina Ventura ([email protected])
Keywords: Adenocarcinoma, Lung, NSCLC, Non-small-cell lung cancer, non-small-cell lung carcinoma, respiratory, pulmonary, neoplasm, tumor, tumour, cancer, carcinoma, squamous cell, large cell, adenosquamous, Sarcomatoid, B7 H1, B7H, B7-H1, PD L1, PD-L1, PDL-1, CD274, CD 274, Tmb, tumo?r mutation*load, tumo?r mutation* burden, programmed cell death 1, programmed cell death 1 receptor, CD279, CD 279
Publication Date: April 16, 2024
Countries of Application: United States
Guideline Publication Status: Published
Languages: English
Authors: CAP (US)
Publication Year: 2024